Skip to Content

PRASCO 326 (Phenylephrine and Guaifenesin SR 25 mg / 900 mg)

Pill with imprint PRASCO 326 is White, Capsule-shape and has been identified as Phenylephrine and Guaifenesin SR 25 mg / 900 mg. It is supplied by Prasco Laboratories.

Guaifenesin/phenylephrine is used in the treatment of cough and nasal congestion; sinus symptoms and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Guaifenesin/phenylephrine 25 mg / 900 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for PRASCO 326

Phenylephrine and Guaifenesin SR

Imprint
PRASCO 326
Strength
25 mg / 900 mg
Color
White
Shape
Capsule-shape
Availability
Rx and/or OTC
Drug Class
Upper respiratory combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Prasco Laboratories
National Drug Code (NDC)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.